Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS

Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS–TIMI 16) trial

Published:2005-03 Issue:3 Volume:149 Page:444-450
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Smith Charles S.,Cannon Christopher P.,McCabe Carolyn H.,Murphy Sabina A.,Bentley Jane,Braunwald Eugene

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N. Engl. J. Med.,1996

3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N. Engl. J. Med.,1998

4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo controlled trial;Lancet,2002

5. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N. Engl. J. Med.,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Management of Blood Lipid Levels with Non-Statin Lipid-Lowering Drugs in Acute Coronary Syndrome: A Mini Review;Cardiovascular Drugs and Therapy;2024-06-29

2. Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery;Mayo Clinic Proceedings;2024-05

3. Paradoxical Association Between Dietary Lifestyle and Cardiovascular Risk: Cross-Sectional Analysis of Patient Responses from A Tertiary Care Hospital;International Journal of Life Science and Pharma Research;2022-08-17

4. Joint position statement on “Nutraceuticals for the treatment of hypercholesterolemia” of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA);Nutrition, Metabolism and Cardiovascular Diseases;2017-01

5. Cochrane corner: early statin therapy in acute coronary syndromes—what is the clinical benefit?;Heart;2016-02-23